GOSS
Gossamer Bio Inc
NASDAQ: GOSS · HEALTHCARE · BIOTECHNOLOGY
$0.37
+5.21% today
Updated 2026-04-30
Market cap
$81.79M
P/E ratio
—
P/S ratio
1.69x
EPS (TTM)
$-0.75
Dividend yield
—
52W range
$0 – $4
Volume
18.7M
Gossamer Bio Inc (GOSS) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $114.70M | $48.47M |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | -57.7% |
| Cost of revenue | $0.00 | $0.00 | $297000.00 | $3.09M | $4.27M | $5.17M | $4.43M | $4.38M | $4.15M | $1.00M |
| Gross profit | $0.00 | $0.00 | $-297000.00 | $-3.09M | $-4.27M | $-5.17M | $-4.43M | $-4.38M | $114.70M | $47.47M |
| Gross margin | — | — | — | — | — | — | — | — | 100.0% | 97.9% |
| R&D | $0.00 | $891000.00 | $55.28M | $143.40M | $158.00M | $170.27M | $170.92M | $135.30M | $138.49M | $174.09M |
| SG&A | $83000.00 | $262000.00 | $44.05M | $39.14M | $49.73M | $45.78M | $47.61M | $38.45M | $36.13M | $37.63M |
| Operating income | $-83000.00 | $-6.65M | $-148.99M | $-186.14M | $-210.58M | $-216.12M | $-218.59M | $-183.76M | $-59.92M | $-163.25M |
| Operating margin | — | — | — | — | — | — | — | — | -52.2% | -336.8% |
| EBITDA | $-83000.00 | $-6.65M | $-148.99M | $-179.45M | $-226.43M | $-209.40M | $-211.07M | $-161.92M | $-39.97M | $-162.25M |
| EBITDA margin | — | — | — | — | — | — | — | — | -34.8% | -334.7% |
| EBIT | $-83000.00 | $-7.81M | $-149.29M | $-182.54M | $-230.69M | $-214.56M | $-215.50M | $-166.31M | $-44.12M | $-163.25M |
| Interest expense | $0.00 | $118000.00 | $12000.00 | $0.00 | $12.67M | $19.44M | $13.88M | $13.51M | $11.52M | $10.99M |
| Income tax | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-83000.00 | $-6.77M | $-146.97M | $-180.82M | $-243.36M | $-234.00M | $-229.38M | $-179.82M | $-56.53M | $-170.37M |
| Net income growth (YoY) | — | -8057.8% | -2070.6% | -23.0% | -34.6% | +3.8% | +2.0% | +21.6% | +68.6% | -201.4% |
| Profit margin | — | — | — | — | — | — | — | — | -49.3% | -351.5% |